Related Experiment Videos
Microbial keratitis: what's the preferred initial therapy? View 2: Empirical fluoroquinolone therapy is sufficient
The British Journal of Ophthalmology
|August 21, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Myogel supports the ex-vivo amplification of corneal epithelial cells.
Experimental eye research·2008
Moraxella keratitis: predisposing factors and clinical review of 95 cases.
The British journal of ophthalmology·2006
Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.
The British journal of ophthalmology·2006
Blepharokeratoconjunctivitis in children: diagnosis and treatment.
The British journal of ophthalmology·2005
The Endophthalmitis Population Study of Western Australia (EPSWA): first report.
The British journal of ophthalmology·2003
An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.
Clinical & experimental ophthalmology·2002
Pythium keratitis: experience from Thailand.
The British journal of ophthalmology·2026
Association of fenofibrate use with progression of ocular disease in individuals with diabetes.
The British journal of ophthalmology·2026
Aflibercept 8 mg versus faricimab for macular oedema due to retinal vein occlusion: a systematic review and network meta-analysis.
The British journal of ophthalmology·2026
Sleep disturbance and incident depressive symptoms in patients with glaucoma: a longitudinal study of the LIGHT cohort.
The British journal of ophthalmology·2026
Association of glaucoma and glaucoma treatments with cataract in the UK Biobank: a cross-sectional observational study.
The British journal of ophthalmology·2026
Bacteriophage-derived ectolysin: a promising antimicrobial against fluoroquinolone-resistant MRSA.
The British journal of ophthalmology·2026
Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing.
Frontiers in tuberculosis·2026